The Department of Health and Human Services (HHS) on October 9, 2026, expressed its support for the Drug Enforcement Administration's (DEA) initiative to schedule synthetic kratom extracts. This endorsement aligns with the DEA's earlier announcement in July regarding plans to temporarily classify a psychoactive compound derived from kratom.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
HHS supports DEA's decision to schedule synthetic kratom extracts
The HHS has endorsed the DEA's decision to regulate synthetic kratom extracts. This follows the DEA's announcement in July about plans to temporarily schedule a psychoactive compound from kratom.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
HHS endorses DEA move to schedule synthetic kratom extracts
Neutral Headline
HHS supports DEA's decision to schedule synthetic kratom extracts